Marketplace: Why the Government Believes Seniors Are Paying $200 Million More for Drugs Than They Need To
Federal health officials say a controversial program that allows hospitals to purchase drugs at deep discounts needs some fixing.
Inside Sources: Reforming 340B Makes Sense
Even as health reform dominates much of the media landscape and the policy arena in Washington, there are many health
The National Law Review: The Uncertain Future of the 340B Drug Discount Program
A Here we are in March 2017 and no one is sure where things stand with the 340B Drug Discount
ICYMI: Congress Calls For Increased Oversight and Transparency of 340B Program
The House Energy & Commerce Subcommittee on Oversight and Investigations held a hearing last Tuesday to examine the Health Resources
AIR340B Gains Four New Members
The Alliance for Integrity and Reform of 340B (AIR340B) announced the addition of four new members to the coalition: Citizens
Morning Consult: 340B Is a Good Idea Gone Bad
Defenders of the 340B Drug Discount Program say it is vital to safety net hospitals and the patients they serve.
Morning Consult: How to Start Lowering Drug Prices Now
President Donald Trump took an important step in the right direction when he recently met with pharmaceutical executives and expressed
OncLive: Who Is at the Controls of 340B?
The 340B Drug Pricing Program, designed to provide support for out-patient drug purchases, severely lacks federal oversight, said BRG Healthcare,
Stat News: This Federal Drug Discount Program Is Actually Boosting Cancer Care Costs
Given its name, you’d expect the federal 340B Drug Discount Program to save money for the American health system. When
Fact Sheet Compares, Examines Distribution of Physician Administered Drugs Among 340B and Non-340B Hospitals
WASHINGTON, D.C. (February 2, 2016) – A new fact sheet released today by the Alliance for Integrity and Reform of 340B (AIR340B) uses research